Buy on Amazon
https://www.ebooknetworking.net/books_detail-1930808844.html
The Sanford Guide to Antimicrobial Therapy 2015
Book Details
PublisherAntimicrobial Therapy
ISBN / ASIN1930808844
ISBN-139781930808843
AvailabilityUsually ships in 1-2 business days
Sales Rank81,990
CategoryMedical
MarketplaceUnited States 🇺🇸
Description
The classic pocket reference in print is in its 45th edition for 2015. Content is organized in tables that cover all aspects of treatment plus comprehensive anti-infective drug information and many useful tools. Recommendations are evidence-based and extensively referenced. Generations of physicians have relied on this edition to help them make informed treatment decisions at the point of care.
The content has been updated to reflect current best-evidence recommendations for treatment of bacterial, fungal, mycobacterial, parasitic and viral infections, newly approved drugs, new indications for existing drugs and references to new reports in the literature.
Available in print in pocket size, spiral bound and large library editions.
New material and areas of significant change in this 45th edition include:
HCV treatment (Table 14G): Expanded treatment options using the newest direct acting agents (DAA) for
interferon-free therapy based on the latest guidelines.
Parasitic diseases (Table 13A): Treatment of parasitic diseases has been comprehensively updated.
Antiretroviral therapy (Table 14): New once daily single tablet regimens have been
added.
Antibacterial drug information (Table 9, Table 10): Pharmacology data and adverse effects summary have
been extensively updated.
Resistant Bacteria (Tables 1, 5, & 6): Updates reflect the latest data and treatment options, including new
agents for treatment of resistant S. aureus.
The content has been updated to reflect current best-evidence recommendations for treatment of bacterial, fungal, mycobacterial, parasitic and viral infections, newly approved drugs, new indications for existing drugs and references to new reports in the literature.
Available in print in pocket size, spiral bound and large library editions.
New material and areas of significant change in this 45th edition include:
HCV treatment (Table 14G): Expanded treatment options using the newest direct acting agents (DAA) for
interferon-free therapy based on the latest guidelines.
Parasitic diseases (Table 13A): Treatment of parasitic diseases has been comprehensively updated.
Antiretroviral therapy (Table 14): New once daily single tablet regimens have been
added.
Antibacterial drug information (Table 9, Table 10): Pharmacology data and adverse effects summary have
been extensively updated.
Resistant Bacteria (Tables 1, 5, & 6): Updates reflect the latest data and treatment options, including new
agents for treatment of resistant S. aureus.










